Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
FDMT
PRME
Add up to 3 more stocks
FDMT
4D Molecular Therapeutics, Inc.
-0.83%
$12.81-0.11Delayed quote: Oct 6, 2026, 2:55 PM EDT
Market Cap
$669.77M
52W Range
$6.96 - $16.93
PRME
Prime Medicine, Inc.
+11.09%
$3.57+0.36Delayed quote: Oct 6, 2026, 2:55 PM EDT
Market Cap
$644.06M
52W Range
$2.67 - $6.85
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.64 | 16.18 |
| P/S Ratio | 7.28 | 158.13 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 91.0% | -58.0% |
| Operating Margin | -187.2% | -4498.1% |
| Net Margin | -194.7% | -4613.1% |
| ROE | -44.0% | -472.0% |
| ROA | -36.4% | -75.5% |
| ROIC | -44.3% | -90.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 8.03 | 3.05 |
| Quick Ratio | 8.03 | 3.05 |
| Debt/Equity | 0.10 | 2.83 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.